Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

Cancer

Volumn 79, Issue 4, 1997, Pages 772-779

  Silberman, Mark A ^a   Partin, Alan W ^a   Veltri, Robert W ^b   Epstein, Jonathan I ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UroCor   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

microvessel density; progression; prostate carcinoma; stage; tumor angiogenesis

Indexed keywords

ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; TUMOR BLOOD FLOW;

ADENOCARCINOMA; HUMANS; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0031046552     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X     Document Type: Article

References (32)

1. Parker SC, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA 1996;46(1):5-27.
2. Franks LM. Latent carcinoma of the prostate. J Pathol Bacterial 1954;68:603-14.
3. Gimbrone MA, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-76.
4. Mahadevan V, Hart IR. Metastasis and angiogenesis. Acta Oncol 1990;29(1):97-102.
5. Greene HSN. Heterologous transplantation of mammalian tumors. J Exp Med 1941;73:461.
6. Liotta LA, Kleinerman J, Saidel GM. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976;36:889-94.
7. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
8. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22:1205-9.
9. Chodak GW, Haudenschild C, Gittes RF, Folkman J. Angiogenic activity as a marker of neoplastic and of preneoplastic lesions of the human bladder. Ann Surg 1980;192:762-71.
10. Sillman F, Boyce J, Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am J Obstet Gynecol 1981;139:154-9.
11. Brem SS, Jensen HM, Gullino PM. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 1978;41(1):239-44.
12. Srivastava A, Laidler P, Davies RP, Morgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988;133(2):419-23.
13. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991;324(1):1-8.
14. Horak ER, Leek R, Klenk N, LeHeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast carcinoma. Lancet 1992;340:1120-4.
15. Weidner N, Folkman J, Pozza F, Pierantonio B, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
16. Gasparini G, Weidner N, Pierantonio B, Maluta S, Dalla PP, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12(3):454-66.
17. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
18. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP. The relationship of angiogenesis to biological activity in human squamous carcinomas of the head and neck. Ann Plast Surg 1994;32(6):588-94.
19. Parums DV, Cordell JL, Michlein D, Hayet AB, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects endothelium associated antigen on routinely processed tissue section. J Clin Pathol 1990;43:752-7.
20. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-6.
21. Siegal JA, Enyou AB, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995;75:2545-51.
22. Deering RE, Bigler SA, Brown M, Brawer MK. Microvascularity in benign prostatic hyperplasia. Prostate 1995;26:111-5.
23. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, et al. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992;168:257-62.
24. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
25. Fregene TA, Khanuja PS, Noto AC, Gehani SK, Van Egmont EM, Luz DA. Tumor-associated angiogenesis in prostate cancer. Anticancer Res 1993;13:2377-81.
26. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994;73:678-87.
27. Hall MC, Troncoso P, Pollack A, Zhou HYE, Zagars GK, Chang LWK, et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 1994;44:869-75.
28. Furusato M, Wakui S, Sasaki H, Ito K, Ushigome S. Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 1994;70:1244-6.
29. Brawer MK, Jonsson E, Gibbons RP, Deering RE, Bigler SA, Preston SD. Extent of prostate neuvascularity predicts progression in patients with pathologic stage C adenocarcinoma treated with radical prostatectomy. J Urol 1994; 151:289A,
30. Partin AW, Steinberg GD, Pitcock RV, et al. Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 1992;70:161-8.
31. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 1994;271:368-74.
32. Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996;48:47-57.